| đ Image | |
| Company type | S.A. (corporation) |
|---|---|
| Euronext: VIRP CAC Mid 60 | |
| ISIN | FR0000031577 đ Edit this on Wikidata |
| Industry | Animal Health Care |
| Founded | 1968 |
| Founder | Pierre-Richard Dick |
| Headquarters | , |
Number of locations | 35 subsidiaries |
Area served | More than 100 countries |
Key people | Paul Martingell |
| Products | Antibiotics, vaccines, dermatology, antiparasitics, dental hygiene... |
| Revenue | đ Increase 1,247 M⏠(2023) |
Number of employees | 6,400 (2025)[1] |
| Website | corporate.virbac.com |
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the 6th[2] the largest veterinarian pharmaceutical group with a turnover of 1,397 million euros in 2024 (62% companion animal and 38% food producing animal). The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME.
History
[edit]Virbac (acronym of virology and bacteriology) is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968[3] by veterinarian Pierre-Richard Dick. Since his death in 1992, his youngest daughter, Marie-HĂ©lĂšne Dick-Madelpuech, also a veterinary surgeon, has chaired the Board of Directors.
In 1985, Virbac was listed on the stock exchange.[4]
In June 2025, Paul Martingell is announced as the new Chief Executive Officer of Virbac, effective September 2025, following the resignation of SĂ©bastien Huron in September 2024. In the meantime, Habib Ramdani serves as interim CEO.[5][6]
Activities
[edit]The company has 6,400 employees and is now present in over 100 countries with 35 sales subsidiaries. Its production is located in 10 countries among which France, the US, Mexico, Brazil, Vietnam. It also has eight research and development centers located in the United States, Mexico, Chile, Uruguay, France, Vietnam, Taiwan and Australia.[7] It generates nearly 60% of its revenues outside France.
Its product range is designed to cover the main pathologies in companion animals and livestock: internal and external parasiticides (collars and pipettes), antibiotics, vaccines, diagnostic tests, dog and cat nutrition, dermatology, dental hygiene, reproductive, aquaculture, anesthesia, geriatrics and electronic identification (pets, horses, exotic petsâŠ).
References
[edit]- ^ "La société de santé animale Virbac en pleine forme pour débuter l'année". 16 April 2025. Retrieved 18 October 2025.
- ^ "Animal health: Virbac announces 2-digits growth for 2012". 12 March 2013. Retrieved 29 December 2015.
- ^ "Investir en Bourse dans la pharmacie vétérinaire : faut-il miser sur Virbac ou Vetoquinol ?". Les Echos. March 21, 2025. Retrieved September 11, 2025.
- ^ "Bénéteau change d'équipe de direction : Bruno Thivoyon nouveau directeur, Yves Lyon-Caen président". Ouest France. April 28, 2022. Retrieved October 18, 2025.
- ^ "Paul Martingell va prendre les commandes du laboratoire Virbac, spécialiste de la santé animale". L'Usine Nouvelle (in French). June 20, 2025. Retrieved October 13, 2025.
- ^ "Virbac : bonne nouvelle saluée". Boursier (in French). June 20, 2025. Retrieved October 13, 2025.
- ^ "Key figures 2014". Virbac. Retrieved 29 December 2015.